246 related articles for article (PubMed ID: 33402569)
1. Quantitative detection of SRY-Box 21 (
Moradi K; Babaei E; Hosseinpour Feizi MA; Safaralizadeh R; Rezvani N
Indian J Cancer; 2021; 58(2):217-224. PubMed ID: 33402569
[TBL] [Abstract][Full Text] [Related]
2. High potential of
Moradi K; Babaei E; Rezvani N; Safaralizadeh R; Bashiri H; Feizi MAH
Indian J Cancer; 2020; 57(2):166-171. PubMed ID: 32445320
[TBL] [Abstract][Full Text] [Related]
3. Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients.
Guo Q; Song Y; Zhang H; Wu X; Xia P; Dang C
Med Oncol; 2013 Dec; 30(4):695. PubMed ID: 23963856
[TBL] [Abstract][Full Text] [Related]
4. Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
Vega-Benedetti AF; Loi E; Moi L; Orrù S; Ziranu P; Pretta A; Lai E; Puzzoni M; Ciccone L; Casadei-Gardini A; Cabras F; Fortunato F; Restivo A; Zorcolo L; Scartozzi M; Zavattari P
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599859
[TBL] [Abstract][Full Text] [Related]
5. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of quantifying
Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
[TBL] [Abstract][Full Text] [Related]
7. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.
Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H
Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908
[TBL] [Abstract][Full Text] [Related]
8. A panel of genes methylated with high frequency in colorectal cancer.
Mitchell SM; Ross JP; Drew HR; Ho T; Brown GS; Saunders NF; Duesing KR; Buckley MJ; Dunne R; Beetson I; Rand KN; McEvoy A; Thomas ML; Baker RT; Wattchow DA; Young GP; Lockett TJ; Pedersen SK; Lapointe LC; Molloy PL
BMC Cancer; 2014 Jan; 14():54. PubMed ID: 24485021
[TBL] [Abstract][Full Text] [Related]
9.
Liu L; Liu C; Fotouhi O; Fan Y; Wang K; Xia C; Shi B; Zhang G; Wang K; Kong F; Larsson C; Hu S; Xu D
Oncologist; 2017 Oct; 22(10):1178-1188. PubMed ID: 28754720
[TBL] [Abstract][Full Text] [Related]
10. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
11. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.
Lenhard K; Bommer GT; Asutay S; Schauer R; Brabletz T; Göke B; Lamerz R; Kolligs FT
Clin Gastroenterol Hepatol; 2005 Feb; 3(2):142-9. PubMed ID: 15704048
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.
Wang DR; Tang D
World J Gastroenterol; 2008 Jan; 14(4):524-31. PubMed ID: 18203283
[TBL] [Abstract][Full Text] [Related]
13. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
[TBL] [Abstract][Full Text] [Related]
14. Value of methylation markers in colorectal cancer (Review).
Kong C; Fu T
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34212989
[TBL] [Abstract][Full Text] [Related]
15. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
16. TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis.
Bagheri H; Mosallaei M; Bagherpour B; Khosravi S; Salehi AR; Salehi R
J Gene Med; 2020 Aug; 22(8):e3189. PubMed ID: 32196834
[TBL] [Abstract][Full Text] [Related]
17. Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.
Rademakers G; Massen M; Koch A; Draht MX; Buekers N; Wouters KAD; Vaes N; De Meyer T; Carvalho B; Meijer GA; Herman JG; Smits KM; van Engeland M; Melotte V
Clin Epigenetics; 2021 Apr; 13(1):80. PubMed ID: 33858496
[TBL] [Abstract][Full Text] [Related]
18. Analysis of
Siri G; Alesaeidi S; Dizghandi SE; Alani B; Mosallaei M; Soosanabadi M
J Cancer Res Ther; 2022 Dec; 18(Supplement):S354-S358. PubMed ID: 36510988
[TBL] [Abstract][Full Text] [Related]
19. Stool DNA methylation assays in colorectal cancer screening.
Kadiyska T; Nossikoff A
World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070
[TBL] [Abstract][Full Text] [Related]
20. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis.
Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B
Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]